Martingale Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,914
Closed -$451K 841
2022
Q1
$451K Sell
20,914
-8,715
-29% -$198K 0.01% 659
2021
Q4
$818K Sell
29,629
-4,693
-14% -$129K 0.01% 541
2021
Q3
$892K Buy
34,322
+25,910
+308% +$693K 0.01% 535
2021
Q2
$229K Buy
+8,412
New +$205K ﹤0.01% 779
2020
Q4
Sell
-28,800
Closed -$348K 874
2020
Q3
$348K Sell
28,800
-232,752
-89% -$2.21M ﹤0.01% 882
2020
Q2
$2.66M Sell
261,552
-10,205
-4% -$105K 0.03% 447
2020
Q1
$2.83M Buy
271,757
+58,737
+28% +$737K 0.04% 412
2019
Q4
$3.41M Buy
213,020
+1,900
+0.9% +$29K 0.03% 470
2019
Q3
$3.89M Buy
211,120
+20,602
+11% +$403K 0.04% 437
2019
Q2
$3.75M Buy
190,518
+3,383
+2% +$68.9K 0.04% 450
2019
Q1
$4.28M Buy
187,135
+12,900
+7% +$280K 0.05% 406
2018
Q4
$3.51M Buy
174,235
+6,570
+4% +$136K 0.05% 408
2018
Q3
$3.65M Sell
167,665
-23,709
-12% -$527K 0.04% 396
2018
Q2
$4.26M Sell
191,374
-35,521
-16% -$726K 0.05% 356
2018
Q1
$3.91M Buy
226,895
+5,503
+2% +$91.8K 0.05% 354
2017
Q4
$3.68M Sell
221,392
-16,288
-7% -$278K 0.05% 368
2017
Q3
$4.06M Buy
237,680
+19,712
+9% +$331K 0.05% 363
2017
Q2
$3.53M Buy
217,968
+8,104
+4% +$128K 0.05% 384
2017
Q1
$3.64M Buy
209,864
+12,401
+6% +$207K 0.05% 372
2016
Q4
$3.33M Buy
197,463
+51,395
+35% +$857K 0.05% 425
2016
Q3
$2.56M Buy
146,068
+89,200
+157% +$1.45M 0.04% 450
2016
Q2
$818K Buy
56,868
+23
+0% +$287 0.01% 568
2016
Q1
$699K Buy
+56,845
New +$628K 0.01% 589

Other funds holding ANGO

Martingale Asset Management's ANGO Position: Q2 2022 in Review

Martingale Asset Management sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 20,914 shares — an estimated $451K sold.

Martingale Asset Management first reported a position in ANGO in Q1 2016 and held it in 23 quarters. The position peaked at $4.28M in Q1 2019. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.

  • Martingale Asset Management reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
  • Martingale Asset Management sold 20,914 AngioDynamics shares in Q2 2022, an estimated $451K.
  • Martingale Asset Management first reported a position in AngioDynamics in Q1 2016 and held it in 23 quarters.
  • Martingale Asset Management's AngioDynamics position peaked at $4.28M in Q1 2019.
  • 134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.

Based on Martingale Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.